title: A prospective postmarket study to evaluate the safety and efficacy of a new peripherally inserted central catheter stabilization system.
abstract: An initial postmarket study of the SecurAcath used with 5 Fr peripherally inserted central catheters (PICCs) was conducted with 68 adult patients at 3 different institutions in the United States. PICCs were placed in both outpatients and inpatients, with patients in critical care and medical/surgical units, home care, and extended care facilities. Sixty-two (91.2%) of the patients completed therapy without a securement-related device malfunction or device-related adverse event associated with the securement system. The device was readily accepted by both patients and nursing staff. The SecurAcath represents a novel, safe, and effective method for catheter securement.
authors.affiliation: Community Care Physicians, Latham, New York, USA. egang@mail.amc.edu
authors.forename: Gail M
authors.initials: GM
authors.lastname: Egan
authors.forename: Gary P
authors.initials: GP
authors.lastname: Siskin
authors.forename: Robert
authors.initials: R
authors.lastname: Weinmann
authors.forename: Margy M
authors.initials: MM
authors.lastname: Galloway
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000295:instrumentation / Q000592:standards*; D002406:Catheterization, Peripheral / Q000009:adverse effects / Q000295:instrumentation / Q000592:standards*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D011446:Prospective Studies; D055815:Young Adult